Literature DB >> 15322482

Antiretroviral treatment in resource-poor settings: what can we learn from the existing programmes in Thailand?

Praphan Phanuphak1.   

Abstract

Here we review a number of issues of relevance to the scale-up of antiretroviral therapy in Thailand. Thailand has an estimated number of people living with HIV/AIDS of approximately 600,000. Currently less than 10% of those are receiving highly active antiretroviral therapy. Government commitment to increase the numbers of individuals being treated has increased because of advocacy from various sectors of society, most importantly from organizations of individuals living with HIV/AIDS, decreasing antiretroviral drug prices, the availability of external funds, and the example of successful treatment initiatives by non-governmental organizations, academia and the private sector. It has also been prompted by the hosting of the 2004 International AIDS Conference in Bangkok.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322482     DOI: 10.1097/00002030-200406003-00007

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

Review 1.  HIV antiretroviral therapy in resource-limited settings: experiences from Haiti.

Authors:  Alysa Krain; Daniel W Fitzgerald
Journal:  Curr HIV/AIDS Rep       Date:  2005-06       Impact factor: 5.071

Review 2.  Extending HIV care in resource-limited settings.

Authors:  Kara Wools-Kaloustian; Sylvester Kimaiyo
Journal:  Curr HIV/AIDS Rep       Date:  2006-11       Impact factor: 5.071

3.  Dyslipidemia and adherence to the Mediterranean diet in Croatian HIV-infected patients during the first year of highly active antiretroviral therapy.

Authors:  Drago Turcinov; Christine Stanley; Jesse A Canchola; George W Rutherford; Thomas E Novotny; Josip Begovac
Journal:  Coll Antropol       Date:  2009-06

4.  Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy.

Authors:  Akihiko Saitoh; Terence Fenton; Carmelita Alvero; Courtney V Fletcher; Stephen A Spector
Journal:  Antimicrob Agents Chemother       Date:  2007-09-24       Impact factor: 5.191

5.  Impact of nucleoside reverse transcriptase inhibitors on mitochondrial DNA and RNA in human skeletal muscle cells.

Authors:  Akihiko Saitoh; Richard H Haas; Robert K Naviaux; Neurita G Salva; Justine K Wong; Stephen A Spector
Journal:  Antimicrob Agents Chemother       Date:  2008-06-09       Impact factor: 5.191

6.  Simplified Assessment of Antiretroviral Adherence and Prediction of Virological Efficacy in HIV-Infected Patients in Cambodia.

Authors:  Olivier Segeral; Yoann Madec; Boroath Ban; Vara Ouk; Chan Roeurn Hak; Clotilde Le Tiec; Eric Nerrienet; Cécile Goujard; Anne Marie Taburet; Jean Francois Delfraissy; Arnaud Fontanet
Journal:  AIDS Res Treat       Date:  2009-12-31

7.  Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand.

Authors:  Woottichai Khamduang; Catherine Gaudy-Graffin; Nicole Ngo-Giang-Huong; Gonzague Jourdain; Alain Moreau; Nuananong Luekamlung; Guttiga Halue; Yuwadee Buranawanitchakorn; Sura Kunkongkapan; Sudanee Buranabanjasatean; Marc Lallemant; Wasna Sirirungsi; Alain Goudeau
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.